Role of PCSK9 Inhibitors in Patients with Familial Hypercholesterolemia

Patients with familial hypercholesterolemia (FH) are at high or very high risk for cardiovascular disease. Those with heterozygous FH (HeFH) often do not reach low-density lipoprotein cholesterol (LDL-C) targets with statin and ezetimibe therapy, and those with homozygous FH (HoFH) usually require a...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Endocrinol Metab (Seoul)
Egile Nagusiak: Tomlinson, Brian, Patil, Nivritti Gajanan, Fok, Manson, Lam, Christopher Wai Kei
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Korean Endocrine Society 2021
Gaiak:
Review Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8090480/
https://ncbi.nlm.nih.gov/pubmed/33866776
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3803/EnM.2021.964
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak